News
Bill Anderson will stay at the helm of the pharmaceutical company until March 2029, after the supervisory board extended his ...
Premier League newcomers Sunderland have reportedly joined Inter Milan in the race for Bayer Leverkusen star Granit ...
Germany's Bayer said on Wednesday that its supervisory board had extended the contract of CEO Bill Anderson until March 31, ...
Joining Bayer Leverkusen from Union Berlin in 2021, Robert Andrich is now one of the club’s longest serving players with 153 ...
Bayer is a deep contrarian play, trading at less than 6x P/E, with potential for 100%+ upside if litigation risks subside.
5don MSN
The hot flashes and night sweats that plague breast cancer survivors during years-long hormone-suppressing therapy are eased ...
2d
Zacks Investment Research on MSNBayer Gets FDA Nod for Label Expansion of Kerendia in Heart FailureBayer AG BAYRY announced that the FDA has approved a label expansion of kidney disease drug Kerendia (finerenone). The ...
Morning Footy ...
Sunderland are interested in signing Granit Xhaka from Bayer Leverkusen; the 32-year-old has three years left on his current ...
The use of SGLT2 inhibitors has been a game-changer in the treatment of heart failure (HF). Now, another drug class has ...
Bayer’s Kerendia (finerenone) has been approved by the US Food and Drug Administration (FDA) to treat heart failure (HF) patients with left ventricular ejection fraction (LVEF) of at least 40%.
While Astellas’ Veozah was the first neurokinin 3 (NK-3) receptor antagonist approved for menopause, Lynkuet is the first ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results